Last update 22 Oct 2025

EVO-46135

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
EVO 46135, EVO46135
Target-
Action
modulators
Mechanism
Immunomodulators
Therapeutic Areas
Infectious Diseases
Active Indication-
Inactive Indication
Human Metapneumovirus InfectionRespiratory Syncytial Virus Infections
Originator Organization
EVEC, Inc.EVEC, Inc.
Active Organization-
Inactive Organization
EVEC, Inc.EVEC, Inc.
License Organization-
Drug Highest PhasePendingDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with EVO-46135
Login to view more data
100 Translational Medicine associated with EVO-46135
Login to view more data
100 Patents (Medical) associated with EVO-46135
Login to view more data
100 Deals associated with EVO-46135
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Human Metapneumovirus InfectionDiscovery
Japan
EVEC, Inc.EVEC, Inc.
-
Respiratory Syncytial Virus InfectionsDiscovery
Japan
EVEC, Inc.EVEC, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free